2 completed, 2 recruiting, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Recruiting 2, Terminated 1 |
Follow Choriocarcinoma: new trials by email Literature Review of Choriocarcinoma trials Research Report on Choriocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles ) - Germ Cell Tumor | Phase 2 | Recruiting | N.N. Petrov National Medical Research Center of Oncology | 25 | 2024-03-01 | 2025-08-03 |
| A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT Biospecimen Collection, Carboplatin, Etoposide - Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma | Phase 2 | Recruiting | Children's Oncology Group | 160 | 2021-07-13 | 2026-09-23 |
| Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) TRC105, Bevacizumab - Gestational Trophoblastic Neoplasia, Choriocarcinoma | Phase 2 | Terminated | Tracon Pharmaceuticals Inc. | 3 | 2016-03-01 | 2019-07-23 |
| TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma TRC105, Bevacizumab - Choriocarcinoma | Phase 2 | Completed | Tracon Pharmaceuticals Inc. | 2 | 2015-01-01 | 2019-06-11 |
| A Trial for Patients With Gestational Trophoblastic Disease Pemetrexed - Trophoblastic Neoplasms, Uterine Neoplasms | Phase 2 | Completed | Eli Lilly and Company | 50 | 2006-07-01 | 2007-08-09 |
Teratoma (2) · Carcinoma, Embryonal (1) · Endodermal Sinus Tumor (1) · Germinoma (1) · Gestational Trophoblastic Disease (1) · Hydatidiform Mole (1) · Neoplasms, Germ Cell and Embryonal (1) · Nonseminomatous germ cell tumor (1) · Seminoma (1) · Trophoblastic Neoplasms (1) · Trophoblastic Tumor, Placental Site (1) · Uterine Neoplasms (1)
Adenocarcinoma (5) · Carcinoma (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Glandular and Epithelial (5) · Pregnancy Complications (5) · Pregnancy Complications, Neoplastic (5) · Urogenital Diseases (5) · Neoplasms, Germ Cell and Embryonal (4) · Trophoblastic Neoplasms (4) · Female Urogenital Diseases (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1)
Bevacizumab (2) · carotuximab (2) · Carboplatin (1) · Drug Therapy (1) · Etoposide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Ifosfamide (1) · Magnetic Resonance Spectroscopy (1) · Mesna (1) · Pemetrexed (1) · Peripheral Blood Stem Cell Transplantation (1) · Radiation (1) · Radiotherapy (1) · Reoperation (1)
Tracon Pharmaceuticals Inc. (2) · Children's Oncology Group (1) · Eli Lilly and Company (1) · N.N. Petrov National Medical Research Center of Oncology (1)
United States (4) · Australia (1) · Canada (1) · New Zealand (1) · Russia (1)
Aleksei M Belyaev, MD,DSc,Prof. (1) · Charles Theuer, MD (1) · Charles Theuer, MD, PhD (1) · David Miller, MD (1) · Shannon M MacDonald (1) · Tatyana Yu Semiglazova, MD,DSc,Prof. (1)
U10CA180886 (1)